Brief: Adma Biologics Reports Q3 Loss Per Share Of $0.19

ADMA Biologics

06/11/2019 22:13

Nov 6 (Reuters) - ADMA Biologics Inc  ADMA.O :
    * ADMA BIOLOGICS REPORTS THIRD QUARTER 2019 FINANCIAL
RESULTS AND
HIGHLIGHTS RECENT COMPANY PROGRESS
    * Q3 LOSS PER SHARE $0.19
    * Q3 REVENUE ROSE 71 PERCENT TO $7.2 MILLION
    * Q3 REVENUE ESTIMATE $5.5 MILLION -- REFINITIV IBES DATA
    * Q3 EARNINGS PER SHARE ESTIMATE $-0.23 -- REFINITIV IBES
DATA
    * AT SEPTEMBER 30, 2019, CO HAD CASH AND CASH EQUIVALENTS OF
$48.0
MILLION AND ACCOUNTS RECEIVABLE OF $7.3 MILLION

Source text for Eikon:  ID:nGNX8cwRP6 
Further company coverage:  ADMA.O 

 ((Reuters.Briefs@thomsonreuters.com;))